Platform
Features
Pricing
REGENXBIO
Contact
No bio yet
Mark Murphy
Senior Vice President, Finance
Brian Chow
Director, Financial Planning & Analysis
Andy Daughtridge
Senior Manager, SEC Reporting & Technical Accounting
Sarah Thomas
Sr Vice President, Quality
10 people, 0 jobs
This person is not in any offices
4 followers
REGENXBIO is seeking to improve lives through the curative potential of gene therapy. Our NAV® Technology Platform has ushered in a new era of gene therapy innovation.
Industries
Headquarters
Employees
Links
Warner Records
Trevelino/Keller
Vault Insurance
Continuum Global Solutions
Fulwell Entertainment